Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.
about
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyLocal restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyProteomic analysis reveals new cardiac-specific dystrophin-associated proteinsA sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophyNonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene.Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation.Characterization of 65 epitope-specific dystrophin monoclonal antibodies in canine and murine models of duchenne muscular dystrophy by immunostaining and western blot.Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.Specificity and VH sequence of two monoclonal antibodies against the N-terminus of dystrophin.Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin.Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.
P2860
Q24616493-87B3288E-65BD-43F2-915A-995A0A78A1D6Q24643018-93E6A408-2955-4B30-9138-908C5EF7F3C4Q28482614-87E26871-FB34-435A-92E2-46B25A3ADF70Q28543132-1C7AC0E9-15B0-4A52-895F-1412DD47504CQ34221402-3FEE07F2-94DB-4214-B87F-A036B6DBBB11Q34797193-10ADC3C5-05DE-4DDD-A914-224A2F7205A3Q35091666-7E0BE48F-32FF-4EB1-BE3F-E1828285918DQ36326993-462BADA7-BB0D-43AB-9783-574A50270B87Q36688078-F7303008-16EE-40D7-A1C9-4B7269AAE8BCQ37370555-3C71C887-2F1D-4D07-AD55-EED914E3C84CQ41479197-5D0CEE8F-ADFA-47A2-BBB1-2A09E9DD3515Q42951346-3B80440A-8E66-43DD-84B7-78C95A93FDB8Q45875854-7736D895-EF0E-4315-89EB-30F52A254585
P2860
Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Use of epitope libraries to id ...... rophins in muscular dystrophy.
@ast
Use of epitope libraries to id ...... rophins in muscular dystrophy.
@en
type
label
Use of epitope libraries to id ...... rophins in muscular dystrophy.
@ast
Use of epitope libraries to id ...... rophins in muscular dystrophy.
@en
prefLabel
Use of epitope libraries to id ...... rophins in muscular dystrophy.
@ast
Use of epitope libraries to id ...... rophins in muscular dystrophy.
@en
P2860
P1476
Use of epitope libraries to id ...... trophins in muscular dystrophy
@en
P2093
P2860
P304
P407
P577
1993-06-01T00:00:00Z